Dallas Hack
Director/Board Member bei APPLIED UV, INC.
Vermögen: 536 $ am 31.03.2024
Profil
Dallas C.
Hack is currently the Chief Executive Officer & Director at VirTech Bio, Inc. He is also a Director at SteriLumen, Inc., Hemispherian AS, and an Independent Director at Applied UV, Inc. In the past, he worked as an Associate Professor at Virginia Commonwealth University and was a Member of the Order of Military Medical Merit.
Dr. Hack has an undergraduate degree from Andrews University, a graduate degree from The Johns Hopkins University, a doctorate from Loma Linda University, and a graduate degree from the U.S.
Army War College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
APPLIED UV, INC.
0,03% | 16.04.2024 | 360 ( 0,03% ) | 536 $ | 31.03.2024 |
Aktive Positionen von Dallas Hack
| Unternehmen | Position | Beginn |
|---|---|---|
| APPLIED UV, INC. | Director/Board Member | 01.01.2020 |
SteriLumen, Inc.
 SteriLumen, Inc. Industrial MachineryProducer Manufacturing Part of Applied UV, Inc., SteriLumen, Inc. is a private company that develops and sells disinfection solutions for food safety, preservation, and building hygiene standards. The company is based in Greenwood Village, CO. SteriLumen is committed to delivering solutions that address the unique challenges faced by the food and real estate sectors in the region and beyond. The company offers a portfolio of technologically-advanced air purification and surface disinfection systems. The company was founded by Max Munn. | Director/Board Member | - |
Hemispherian AS
 Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Director/Board Member | - |
VirTech Bio, Inc.
 VirTech Bio, Inc. BiotechnologyHealth Technology VirTech Bio, Inc. operates as a biotechnology company. It develops innovative therapies for organ and tissue preservation. The company was founded in 2013 and is headquartered in Beverly, MA. | Chief Executive Officer | 17.03.2022 |
Ehemalige bekannte Positionen von Dallas Hack
| Unternehmen | Position | Ende |
|---|---|---|
| Virginia Commonwealth University | Corporate Officer/Principal | 01.01.2015 |
| Order of Military Medical Merit | Corporate Officer/Principal | - |
Ausbildung von Dallas Hack
| Andrews University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| Loma Linda University | Doctorate Degree |
| U.S. Army War College | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
SteriLumen, Inc.
SteriLumen, Inc. Industrial MachineryProducer Manufacturing Part of Applied UV, Inc., SteriLumen, Inc. is a private company that develops and sells disinfection solutions for food safety, preservation, and building hygiene standards. The company is based in Greenwood Village, CO. SteriLumen is committed to delivering solutions that address the unique challenges faced by the food and real estate sectors in the region and beyond. The company offers a portfolio of technologically-advanced air purification and surface disinfection systems. The company was founded by Max Munn. | Producer Manufacturing |
VirTech Bio, Inc.
VirTech Bio, Inc. BiotechnologyHealth Technology VirTech Bio, Inc. operates as a biotechnology company. It develops innovative therapies for organ and tissue preservation. The company was founded in 2013 and is headquartered in Beverly, MA. | Health Technology |
| Applied UV, Inc. | |
| Order of Military Medical Merit | |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Commercial Services |
